10,358 Shares in Haleon plc (NYSE:HLN) Bought by Hoxton Planning & Management LLC

Hoxton Planning & Management LLC purchased a new position in shares of Haleon plc (NYSE:HLN) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 10,358 shares of the company’s stock, valued at approximately $85,000.

A number of other large investors have also recently bought and sold shares of the business. Barclays PLC boosted its stake in Haleon by 56.4% during the 2nd quarter. Barclays PLC now owns 3,317 shares of the company’s stock worth $28,000 after purchasing an additional 1,196 shares during the period. Hollencrest Capital Management lifted its stake in shares of Haleon by 21.5% in the 1st quarter. Hollencrest Capital Management now owns 7,114 shares of the company’s stock worth $58,000 after acquiring an additional 1,258 shares during the period. Farther Finance Advisors LLC lifted its stake in shares of Haleon by 79.3% in the 2nd quarter. Farther Finance Advisors LLC now owns 2,986 shares of the company’s stock worth $25,000 after acquiring an additional 1,321 shares during the period. Apollon Wealth Management LLC lifted its stake in shares of Haleon by 11.0% in the 1st quarter. Apollon Wealth Management LLC now owns 13,404 shares of the company’s stock worth $109,000 after acquiring an additional 1,332 shares during the period. Finally, Financial Advocates Investment Management lifted its stake in shares of Haleon by 10.5% in the 3rd quarter. Financial Advocates Investment Management now owns 14,849 shares of the company’s stock worth $124,000 after acquiring an additional 1,408 shares during the period. Institutional investors and hedge funds own 6.67% of the company’s stock.

Haleon Stock Up 0.7 %

Shares of NYSE HLN opened at $8.07 on Tuesday. The company has a quick ratio of 0.73, a current ratio of 1.04 and a debt-to-equity ratio of 0.53. Haleon plc has a 52 week low of $7.70 and a 52 week high of $9.05. The firm has a 50-day moving average price of $8.31 and a 200 day moving average price of $8.29. The stock has a market capitalization of $36.83 billion, a price-to-earnings ratio of 28.80, a price-to-earnings-growth ratio of 2.10 and a beta of 0.29.

Haleon Announces Dividend

The business also recently disclosed a semi-annual dividend, which will be paid on Thursday, May 16th. Investors of record on Friday, March 15th will be paid a $0.1064 dividend. This represents a dividend yield of 1.8%. The ex-dividend date of this dividend is Thursday, March 14th. Haleon’s dividend payout ratio (DPR) is 75.00%.

Analyst Ratings Changes

Separately, Argus restated a “buy” rating on shares of Haleon in a research note on Tuesday, March 26th.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.